Clinical relevance of plasma brain natriuretic peptide in patients with Duchenne and Becker muscular dystrophy [1] (multiple letters)

Neuromuscular Disorders

Volumn 15, Issue 7, 2005, Pages 513-514

  Stöllberger, Claudia ^a   Finsterer, Josef ^b   Demachi, Jun ^c   Kagaya, Yutaka ^c  

^a Second Medical Department   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BECKER MUSCULAR DYSTROPHY; BLOOD PRESSURE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; PRIORITY JOURNAL;

EID: 21244488134     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2005.01.015     Document Type: Letter

References (4)

1. J. Demachi Y. Kagaya J. Watanabe Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy Neuromuscul Disord 14 2004 732 739
2. C. Stöllberger S. Leitner W. Kopsa J. Finsterer Left ventricular hypertrabeculation/noncompaction and neuromuscular disorders in idiopathic dilated cardiomyopathy Acta Cardiol 59 2004 425 430
3. J. Finsterer R.E. Bittner M. Grimm Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement Neuromuscul Disord 9 1999 598 600
4. K. Bushby F. Muntoni J.P. Bourke 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy, Naarden, the Netherlands; 7th–9th June 2002 Neuromuscul Disord 13 2003 166 172